PLIVA FDA Approval ANDA 065218

ANDA 065218

PLIVA

FDA Drug Application

Application #065218

Application Sponsors

ANDA 065218PLIVA

Marketing Status

Prescription001

Application Products

001TABLET;ORALEQ 600MG BASE0AZITHROMYCINAZITHROMYCIN

FDA Submissions

ORIG1AP2005-11-14
LABELING; LabelingSUPPL13AP2010-07-30
LABELING; LabelingSUPPL15AP2016-11-08STANDARD
LABELING; LabelingSUPPL19AP2020-01-08STANDARD
LABELING; LabelingSUPPL20AP2020-01-08STANDARD
LABELING; LabelingSUPPL21AP2020-01-08STANDARD
LABELING; LabelingSUPPL22AP2020-01-08STANDARD
LABELING; LabelingSUPPL24AP2021-11-22STANDARD

Submissions Property Types

SUPPL15Null15
SUPPL19Null7
SUPPL20Null7
SUPPL21Null15
SUPPL22Null15
SUPPL24Null15

TE Codes

001PrescriptionAB

CDER Filings

PLIVA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 65218
            [companyName] => PLIVA
            [docInserts] => ["",""]
            [products] => [{"drugName":"AZITHROMYCIN","activeIngredients":"AZITHROMYCIN","strength":"EQ 600MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"Yes"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"AZITHROMYCIN","submission":"AZITHROMYCIN","actionType":"EQ 600MG BASE","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.